Home LiteratureArticle Details
PMID: 1489146 Published · ppublish English Journal Article Research Support, Non-U.S. Gov't Research Support, U.S. Gov't, P.H.S.

Disordered pathways of fibrin turnover in lung lavage of premature infants with respiratory distress syndrome.

The American review of respiratory disease ·Vol. 146 ·No. 2 ·1992-08-00 ·Pages 492-9

Viscardi RM, Broderick K, Sun CC, Yale-Loehr AJ, Hessamfar A, Taciak V, Burke KC, Koenig KB, Idell S

Abstract

Premature infants who have self-limited respiratory distress syndrome (RDS) rapidly improve, whereas infants with a complicated respiratory course are more likely to develop bronchopulmonary dysplasia (BPD), a chronic lung disorder that is the result of prolonged lung injury and impaired healing. The balance of competing activities of coagulation and fibrinolysis may contribute to the premature lung's response to acute injury and determine, in part, whether there is early resolution or protracted alveolar inflammation. To determine the relative activities of the coagulation and fibrinolytic pathways in neonatal lung injury, procoagulant (PC) and plasminogen activator (PA) activities were measured in undiluted cell-free lung lavage samples obtained serially over the first 28 days of life from 11 infants with self-limited RDS, 11 infants with evolving BPD, and 5 mechanically ventilated control infants without lung disease. Lung lavage from all three groups contained readily detectable procoagulant activity due mainly to the tissue factor-Factor VII complex. Plasminogen activator activity was relatively high in control lavage samples but depressed on the first day of life in the two groups of infants with lung disease: median, 0.3814 IU/ml (control); 0.0541 IU/ml (RDS); and 0.0454 IU/ml (BPD), p < 0.05 in each case compared with control. Two infants with severe lung disease had no detectable plasminogen activator activity in lung lavage on the first day of life. Depressed fibrinolytic activity correlated with severity of lung disease assessed radiographically and by pulmonary function measurements. Plasminogen activator activity was due to both tissue plasminogen activator and urokinase.(ABSTRACT TRUNCATED AT 250 WORDS)

MeSH Terms
Apgar Score Baltimore/epidemiology Birth Weight Bronchoalveolar Lavage Fluid/chemistry Bronchopulmonary Dysplasia/epidemiology,etiology Evaluation Studies as Topic Female Fibrin/chemistry,metabolism Fibrinolysis Gestational Age Humans Infant, Newborn Infant, Premature Intensive Care Units, Neonatal Male Plasminogen Activator Inhibitor 1/chemistry Plasminogen Activator Inhibitor 2/chemistry Predictive Value of Tests Respiratory Distress Syndrome, Newborn/complications,metabolism Risk Factors Tissue Plasminogen Activator/chemistry Urokinase-Type Plasminogen Activator/chemistry
Chemicals
Plasminogen Activator Inhibitor 1 Plasminogen Activator Inhibitor 2 Fibrin Tissue Plasminogen Activator Urokinase-Type Plasminogen Activator
Authors & Affiliations
9 authors, click to expand affiliations / ORCID
Viscardi R M
Department of Pediatrics, University of Maryland Hospital, Baltimore 21201.
Broderick K
Sun C C
Yale-Loehr A J
Hessamfar A
Taciak V
Burke K C
Koenig K B
Idell S
Article Info
Journal
The American review of respiratory disease
Abbr.
Am Rev Respir Dis
ISSN
0003-0805
Published
1992-08-00
Pages
492-9
Language
English
Region
United States
NLM ID
0370523
Subset
IM
Grants
NHLBI NIH HHS · K01HL01603 · United States
NHLBI NIH HHS · R01HL37770 · United States
NHLBI NIH HHS · R01HL45018 · United States
Analysis Services
Analysis Services

Contact

No. 2 Wenbo Road, Zhangqiu District, Jinan, Shandong

Qilu Normal University · Genelibs Bioinformatics Lab

750 Shunhua Rd, Jinan

2F, Bldg F, University Science Park

Tel: 0531-88819269

WeChat Official Account

Follow our WeChat subscription account for real-time updates and the latest in medical and biological research.


Business Email

E-mail: [email protected]